<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39555466</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1753-4313</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>The British journal of cardiology</Title><ISOAbbreviation>Br J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular disease development in COVID-19 patients admitted to a tertiary medical centre in Iran.</ArticleTitle><Pagination><StartPage>026</StartPage><MedlinePgn>026</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">026</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5837/bjc.2024.026</ELocationID><Abstract><AbstractText>Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included. Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG). Additionally, 2D transthoracic echocardiography (TTE), and myocardial injury serum biomarkers assays (creatine phosphokinase-MB [CPK-MB] and cardiac troponins [cTn]) were measured once. Manifestations of CVDs, such as chest pain, abnormal serum markers, unstable angina, myocardial infarction (MI), myocarditis, and new-onset hypertension, were documented. The most common symptom was left hemithorax and interscapular pain (317 patients, 46%). New-onset high systolic and diastolic blood pressures were seen in 67 patients (10%). Unstable angina, MI, and myocarditis were, respectively, diagnosed in 20 (2.8%), five (0.7%), and 12 (1.7%) patients. On TTE, pericardial effusion was diagnosed in 139 patients (31.1%). The most common abnormal ECG changes seen were regarding the T-wave, including flat T-wave (148 cases, 21.4%) and inverted T-wave (141 cases, 20.4%). Serum cTn levels were positive or weekly positive in 17 cases (7.4%). The incidence rate of cardiovascular involvements was high in COVID-19 patients.</AbstractText><CopyrightInformation>Copyright © 2024 Medinews (Cardiology) Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kazemi</LastName><ForeName>Erfan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical student, Student Research Committee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daliri</LastName><ForeName>Salman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epidemiologist, Clinical Research Development Unit, Imam Hossein Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaman</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Epidemiologist, Department of Community Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohani-Rasaf</LastName><ForeName>Marsh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epidemiologist, Department of Epidemiology, School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binesh</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Disease Doctor, Department of Infectious Disease.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheibani</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Associated Professor of Cardiology, Clinical Research Development Unit, Imam Hossein Hospital Shahroud University of Medical Sciences, Imam Ave., Shahroud 36169-11151, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Cardiol</MedlineTA><NlmUniqueID>9503762</NlmUniqueID><ISSNLinking>0969-6113</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">electrocardiogram (ECG)</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">unstable angina</Keyword></KeywordList><CoiStatement>Conflicts of interest None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>17</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39555466</ArticleId><ArticleId IdType="pmc">PMC11562573</ArticleId><ArticleId IdType="doi">10.5837/bjc.2024.026</ArticleId><ArticleId IdType="pii">bjc.2024.026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92:401–02. doi: 10.1002/jmv.25678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao CW, Strom JB, Chang JD, Manning WJ. COVID-19-associated stress (Takotsubo) cardiomyopathy. Circ Cardiovasc Imaging. 2020;13:e011222. doi: 10.1161/CIRCIMAGING.120.011222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.120.011222</ArticleId><ArticleId IdType="pmc">PMC7398589</ArticleId><ArticleId IdType="pubmed">32673494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SE, Lameira FS, Rinker EB, Vander Heide RS. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19. Ann Intern Med. 2020;173:1025–7. doi: 10.7326/L20-0882.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-0882</ArticleId><ArticleId IdType="pmc">PMC7506743</ArticleId><ArticleId IdType="pubmed">32726150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kara AA. Multiple thrombi in a child diagnosed with coronavirus disease 2019 treated with cardiac surgery. Turk Gogus Kalp Damar Cerrahisi Derg. 2022;30:277–80. doi: 10.5606/tgkdc.dergisi.2022.22250.</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/tgkdc.dergisi.2022.22250</ArticleId><ArticleId IdType="pmc">PMC9473608</ArticleId><ArticleId IdType="pubmed">36168584</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–8. doi: 10.1038/nature00786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382:2431–40. doi: 10.1056/NEJMoa2006923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006923</ArticleId><ArticleId IdType="pmc">PMC7206933</ArticleId><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686–9. doi: 10.1136/thorax.58.8.686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.58.8.686</ArticleId><ArticleId IdType="pmc">PMC1746764</ArticleId><ArticleId IdType="pubmed">12885985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong E, Castro-Dominguez Y, Brennan J, Oen-Hsiao J. COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient. Catheter Cardiovasc Interv. 2021;97:267–71. doi: 10.1002/ccd.29102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.29102</ArticleId><ArticleId IdType="pmc">PMC7405222</ArticleId><ArticleId IdType="pubmed">32672402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HN, Lee JH, Park HS, et al. A case of COVID-19 with acute myocardial infarction and cardiogenic shock. J Korean Med Sci. 2020;35:e258. doi: 10.3346/jkms.2020.35.e258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e258</ArticleId><ArticleId IdType="pmc">PMC7358062</ArticleId><ArticleId IdType="pubmed">32657091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL Jr., Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76:1244–58. doi: 10.1016/j.jacc.2020.06.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.068</ArticleId><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong N, Cai J, Zhou Y, Liu J, Li F. End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV. JACC Heart Fail. 2020;8:515–17. doi: 10.1016/j.jchf.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7141452</ArticleId><ArticleId IdType="pubmed">32265149</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666–87. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. Therapeutics and COVID-19: living guideline. Geneva: WHO, 2022.  Available from:  https://iris.who.int/bitstream/handle/10665/359774/WHO-2019-nCoV-therapeutics-2022.4-eng.pdf?sequence=1.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917393</ArticleId></ArticleIdList></Reference><Reference><Citation>Son JS, Choi S, Lee G, et al. Blood pressure change from normal to 2017 ACC/AHA defined stage 1 hypertension and cardiovascular risk. J Clin Med. 2019;8:820. doi: 10.3390/jcm8060820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8060820</ArticleId><ArticleId IdType="pmc">PMC6617274</ArticleId><ArticleId IdType="pubmed">31181795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cautela J, Tartiere JM, Cohen-Solal A, et al. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients. Eur J Heart Fail. 2020;22:1357–65. doi: 10.1002/ejhf.1835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1835</ArticleId><ArticleId IdType="pmc">PMC7540603</ArticleId><ArticleId IdType="pubmed">32353213</ArticleId></ArticleIdList></Reference><Reference><Citation>Surawicz B, Childers R, Deal BJ, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. Circulation. 2009;119:e235–e240. doi: 10.1161/CIRCULATIONAHA.108.191095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.191095</ArticleId><ArticleId IdType="pubmed">19228822</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 1997;95:1686–744. doi: 10.1161/01.CIR.95.6.1686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.95.6.1686</ArticleId><ArticleId IdType="pubmed">9118558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrakanas TA, Sniderman AD, Barré PE, Alam A. Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patients. Nephrology (Carlton) 2018;23:69–74. doi: 10.1111/nep.12945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12945</ArticleId><ArticleId IdType="pubmed">27718506</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission &amp; State Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia. Beijing: National Health Commission, 3 March 2020.  Available from:  http://www.kankyokansen.org/uploads/uploads/files/jsipc/protocol_V7.pdf.</Citation></Reference><Reference><Citation>Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–10. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42:206. doi: 10.1093/eurheartj/ehaa190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa190</ArticleId><ArticleId IdType="pmc">PMC7184348</ArticleId><ArticleId IdType="pubmed">32176300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58:1131–4. doi: 10.1515/cclm-2020-0198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0198</ArticleId><ArticleId IdType="pubmed">32119647</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F, Spanevello A, De Ponti R, et al. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020;78:101–06. doi: 10.1016/j.ejim.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7305928</ArticleId><ArticleId IdType="pubmed">32586646</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B, Brady WJ, Bridwell RE, et al. Electrocardiographic manifestations of COVID-19. Am J Emerg Med. 2021;41:96–103. doi: 10.1016/j.ajem.2020.12.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.12.060</ArticleId><ArticleId IdType="pmc">PMC7771377</ArticleId><ArticleId IdType="pubmed">33412365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirmoeeni S, Azari Jafari A, Hashemi SZ, et al. Cardiovascular manifestations in COVID-19 patients: a systematic review and metaanalysis. J Cardiovasc Thorac Res. 2021;13:181–9. doi: 10.34172/jcvtr.2021.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/jcvtr.2021.30</ArticleId><ArticleId IdType="pmc">PMC8493234</ArticleId><ArticleId IdType="pubmed">34630964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sud K, Vogel B, Bohra C, et al. Echocardiographic findings in patients with COVID-19 with significant myocardial injury. J Am Soc Echocardiogr. 2020;33:1054–5. doi: 10.1016/j..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.</ArticleId><ArticleId IdType="pmc">PMC7274620</ArticleId><ArticleId IdType="pubmed">32595004</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CM, Wong RSM, Wu EB, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82:140. doi: 10.1136/pgmj.2005.037515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2005.037515</ArticleId><ArticleId IdType="pmc">PMC2596695</ArticleId><ArticleId IdType="pubmed">16461478</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVIDNET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458–64. doi: 10.15585/mmwr.mm6915e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618–25. doi: 10.1111/j.1365-2362.2009.02153.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2009.02153.x</ArticleId><ArticleId IdType="pmc">PMC7163766</ArticleId><ArticleId IdType="pubmed">19453650</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>